512 related articles for article (PubMed ID: 9815262)
21. Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells.
Spatz M; Eibl N; Hink S; Wolf HM; Fischer GF; Mayr WR; Schernthaner G; Eibl MM
Cell Immunol; 2003 Jan; 221(1):15-26. PubMed ID: 12742378
[TBL] [Abstract][Full Text] [Related]
22. The effect of nicotine on murine CD4 T cell responses.
Zhang S; Petro TM
Int J Immunopharmacol; 1996; 18(8-9):467-78. PubMed ID: 9023586
[TBL] [Abstract][Full Text] [Related]
23. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation.
Murphy EE; Terres G; Macatonia SE; Hsieh CS; Mattson J; Lanier L; Wysocka M; Trinchieri G; Murphy K; O'Garra A
J Exp Med; 1994 Jul; 180(1):223-31. PubMed ID: 7516409
[TBL] [Abstract][Full Text] [Related]
24. CTLA-4 can function as a negative regulator of T cell activation.
Walunas TL; Lenschow DJ; Bakker CY; Linsley PS; Freeman GJ; Green JM; Thompson CB; Bluestone JA
Immunity; 1994 Aug; 1(5):405-13. PubMed ID: 7882171
[TBL] [Abstract][Full Text] [Related]
25. Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice.
Hellings PW; Vandenberghe P; Kasran A; Coorevits L; Overbergh L; Mathieu C; Ceuppens JL
Eur J Immunol; 2002 Feb; 32(2):585-94. PubMed ID: 11828376
[TBL] [Abstract][Full Text] [Related]
26. CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention.
Leng Q; Bentwich Z; Magen E; Kalinkovich A; Borkow G
AIDS; 2002 Mar; 16(4):519-29. PubMed ID: 11872994
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-beta inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response.
Tiemessen MM; Kunzmann S; Schmidt-Weber CB; Garssen J; Bruijnzeel-Koomen CA; Knol EF; van Hoffen E
Int Immunol; 2003 Dec; 15(12):1495-504. PubMed ID: 14645158
[TBL] [Abstract][Full Text] [Related]
28. Elevated CTLA-4 expression on CD4 T cells from periodontitis patients stimulated with Porphyromonas gingivalis outer membrane antigen.
Aoyagi T; Yamazaki K; Kabasawa-Katoh Y; Nakajima T; Yamashita N; Yoshie H; Hara K
Clin Exp Immunol; 2000 Feb; 119(2):280-6. PubMed ID: 10632663
[TBL] [Abstract][Full Text] [Related]
29. CTLA-4 ligation blocks CD28-dependent T cell activation.
Walunas TL; Bakker CY; Bluestone JA
J Exp Med; 1996 Jun; 183(6):2541-50. PubMed ID: 8676075
[TBL] [Abstract][Full Text] [Related]
30. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.
Zhang X; Izikson L; Liu L; Weiner HL
J Immunol; 2001 Oct; 167(8):4245-53. PubMed ID: 11591746
[TBL] [Abstract][Full Text] [Related]
31. CTLA-4 ligation suppresses CD28-induced NF-kappaB and AP-1 activity in mouse T cell blasts.
Olsson C; Riesbeck K; Dohlsten M; Michaëlsson E
J Biol Chem; 1999 May; 274(20):14400-5. PubMed ID: 10318864
[TBL] [Abstract][Full Text] [Related]
32. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.
Fallarino F; Fields PE; Gajewski TF
J Exp Med; 1998 Jul; 188(1):205-10. PubMed ID: 9653097
[TBL] [Abstract][Full Text] [Related]
33. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
Mukherjee S; Maiti PK; Nandi D
J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
[TBL] [Abstract][Full Text] [Related]
34. Nonresponsiveness and susceptibility to CTLA-4 of antigen-exposed CD4 T cells are not regulated by the Bcl-2 family of apoptotic mediators, but can be restored by IL-2.
Hamel ME; Leupers TJ; Kruisbeek AM
Thymus; 1997; 24(4):259-77. PubMed ID: 9493288
[TBL] [Abstract][Full Text] [Related]
35. CTLA-4-Mediated inhibition of early events of T cell proliferation.
Brunner MC; Chambers CA; Chan FK; Hanke J; Winoto A; Allison JP
J Immunol; 1999 May; 162(10):5813-20. PubMed ID: 10229815
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo.
Yi LA; Hajialiasgar S; Chuang E
Int Immunol; 2004 Apr; 16(4):539-47. PubMed ID: 15039384
[TBL] [Abstract][Full Text] [Related]
37. Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking.
Scheipers P; Reiser H
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10083-8. PubMed ID: 9707604
[TBL] [Abstract][Full Text] [Related]
38. Expression and function of CTLA-4 in Th1 and Th2 cells.
Alegre ML; Shiels H; Thompson CB; Gajewski TF
J Immunol; 1998 Oct; 161(7):3347-56. PubMed ID: 9759851
[TBL] [Abstract][Full Text] [Related]
39. Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response.
Ukyo N; Hori T; Yanagita S; Ishikawa T; Uchiyama T
Immunology; 2003 Jun; 109(2):226-31. PubMed ID: 12757617
[TBL] [Abstract][Full Text] [Related]
40. Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes.
Annunziato F; Cosmi L; Liotta F; Lazzeri E; Manetti R; Vanini V; Romagnani P; Maggi E; Romagnani S
J Exp Med; 2002 Aug; 196(3):379-87. PubMed ID: 12163566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
